These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25402582)

  • 1. Biomarkers for Helicobacter pylori infection and gastroduodenal diseases.
    Shiota S; Yamaoka Y
    Biomark Med; 2014; 8(9):1127-37. PubMed ID: 25402582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
    Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
    Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests.
    Hamashima C; Sasazuki S; Inoue M; Tsugane S;
    BMC Cancer; 2017 Mar; 17(1):183. PubMed ID: 28279154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels.
    Yanaoka K; Oka M; Yoshimura N; Mukoubayashi C; Enomoto S; Iguchi M; Magari H; Utsunomiya H; Tamai H; Arii K; Yamamichi N; Fujishiro M; Takeshita T; Mohara O; Ichinose M
    Int J Cancer; 2008 Aug; 123(4):917-26. PubMed ID: 18508314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori infection and markers of gastric cancer risk in Alaska Native persons: a retrospective case-control study.
    Keck JW; Miernyk KM; Bulkow LR; Kelly JJ; McMahon BJ; Sacco F; Hennessy TW; Bruce MG
    Can J Gastroenterol Hepatol; 2014 Jun; 28(6):305-10. PubMed ID: 24945184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis.
    Watanabe M; Kato J; Inoue I; Yoshimura N; Yoshida T; Mukoubayashi C; Deguchi H; Enomoto S; Ueda K; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Tekeshita T; Mohara O; Ushijima T; Ichinose M
    Int J Cancer; 2012 Dec; 131(11):2632-42. PubMed ID: 22383377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori infection and low serum pepsinogen I level as risk factors for gastric carcinoma.
    Kokkola A; Louhimo J; Puolakkainen P; Alfthan H; Haglund C; Rautelin H
    World J Gastroenterol; 2005 Feb; 11(7):1032-6. PubMed ID: 15742409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
    Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males.
    Song M; Camargo MC; Weinstein SJ; Murphy G; Freedman ND; Koshiol J; Stolzenberg-Solomon RZ; Abnet CC; Männistö S; Albanes D; Rabkin CS
    Aliment Pharmacol Ther; 2018 Feb; 47(4):494-503. PubMed ID: 29243850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
    Zhang L; Blot WJ; You WC; Chang YS; Kneller RW; Jin ML; Li JY; Zhao L; Liu WD; Zhang JS; Ma JL; Samloff IM; Correa P; Blaser MJ; Xu GW; Fraumeni JF
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):627-30. PubMed ID: 8824365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutoff Pepsinogen Level for Predicting Unintendedly Eradicated Cases of Helicobacter pylori Infection in Subjects with Seemingly Normal Pepsinogen Levels.
    Kishikawa H; Kimura K; Ito A; Arahata K; Takarabe S; Kaida S; Miyauchi J; Miura S; Kanai T; Nishida J
    Digestion; 2017; 95(3):229-236. PubMed ID: 28355604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low serum pepsinogen I and pepsinogen I/II ratio and Helicobacter pylori infection are associated with increased risk of gastric cancer: 14-year follow up result in a rural Chinese community.
    Zhang X; Xue L; Xing L; Wang J; Cui J; Mi J; Xing X; Wang J; Du Z; Misumi J; Tian Q; Wang L
    Int J Cancer; 2012 Apr; 130(7):1614-9. PubMed ID: 21547904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori and Schistosoma japonicum co-infection in a Chinese population: helminth infection alters humoral responses to H. pylori and serum pepsinogen I/II ratio.
    Du Y; Agnew A; Ye XP; Robinson PA; Forman D; Crabtree JE
    Microbes Infect; 2006 Jan; 8(1):52-60. PubMed ID: 16260169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Searching for New Biomarkers and the Use of Multivariate Analysis in Gastric Cancer Diagnostics.
    Kucera R; Smid D; Topolcan O; Karlikova M; Fiala O; Slouka D; Skalicky T; Treska V; Kulda V; Simanek V; Safanda M; Pesta M
    Anticancer Res; 2016 Apr; 36(4):1967-71. PubMed ID: 27069188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of serum miRNAs as novel non-invasive biomarkers for detection of high risk for early gastric cancer.
    Shiotani A; Murao T; Kimura Y; Matsumoto H; Kamada T; Kusunoki H; Inoue K; Uedo N; Iishi H; Haruma K
    Br J Cancer; 2013 Oct; 109(9):2323-30. PubMed ID: 24104965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori IgA and IgG antibodies, serum pepsinogen I and the risk of gastric cancer: changes in the risk with extended follow-up period.
    Knekt P; Teppo L; Aromaa A; Rissanen H; Kosunen TU
    Int J Cancer; 2006 Aug; 119(3):702-5. PubMed ID: 16496404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm.
    Choi HS; Lee SY; Kim JH; Sung IK; Park HS; Shim CS; Jin CJ
    J Dig Dis; 2014 Jun; 15(6):293-8. PubMed ID: 24602176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study.
    Watabe H; Mitsushima T; Yamaji Y; Okamoto M; Wada R; Kokubo T; Doi H; Yoshida H; Kawabe T; Omata M
    Gut; 2005 Jun; 54(6):764-8. PubMed ID: 15888780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Helicobacter pylori KatA and AhpC antibodies as novel biomarkers for gastric cancer.
    Zhang B; Li HL; Fan Q; Guo F; Ren XY; Zhou HB; Zhu JW; Zhao YS; Tian WJ
    World J Gastroenterol; 2016 Jun; 22(21):5060-7. PubMed ID: 27275098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk of gastric cancer dependent on serological markers of atrophic gastritis: cohort study].
    Reshetnikov OV; Openko TG; Simonova GI; Kurilovich SA; Maliushina SK; Ragino IuI; Voevoda MI
    Vopr Onkol; 2012; 58(5):644-8. PubMed ID: 23600281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.